Concepedia

Author

K. J. Schmidt

University of Lübeck

Also Known As

K G Simon, K J Schmidt, K Schmidt, K. J. SCHMIDT, K. J. Schmidt, K. Schmidt, K.J. Schmidt, KJ Schmidt

29

Publications

392

Citations

9

H-Index

5

Concepts

All Affiliations

University of LübeckRobert Bosch HospitalUniversity Hospital Schleswig-HolsteinGoethe University FrankfurtUniversity Hospital Frankfurt
KJ

About

K. J. Schmidt is an author at University of Lübeck specializing in viral hepatitis, virology, and hepatitis.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

13

2

Viral Hepatitis

1

1

13

3

Hepatitis

1

1

13

4

Infection Control

1

1

13

5

Virology

1

1

13

K. J. Schmidt

×

8

Publications

366

Citations

8

H-Index

YearCitations

Short‐term efficacy of tacrolimus in steroid‐refractory ulcerative colitis – experience in 130 patients

K. J. Schmidt, K Herrlinger, Jörg Emmrich,

Alimentary Pharmacology & Therapeutics

2012

82

Innate Immunity and Colonic Inflammation: Enhanced Expression of Epithelial α-Defensins

Jan Wehkamp, Bettina Schwind, Klaus Herrlinger,

Digestive Diseases and Sciences

2002

81

Minimal renal dysfunction in inflammatory bowel disease is related to disease activity but not to 5‐ASA use

Klaus Herrlinger, Mirja K. Noftz, Klaus Fellermann,

Alimentary Pharmacology & Therapeutics

2001

79

Infliximab as rescue medication for patients with severe ulcerative/indeterminate colitis refractory to tacrolimus

Klaus Herrlinger, Daniel Nicolas Barthel, K. J. Schmidt,

Alimentary Pharmacology & Therapeutics

2010

50

Long-term Outcomes in Steroid-refractory Ulcerative Colitis Treated with Tacrolimus Alone or in Combination with Purine Analogues

K. J. Schmidt, Niklas F. Müller, Daniel C. Baumgart,

Journal of Crohn s and Colitis

2015

23

Prevalence of resistance-associated substitutions and retreatment of patients failing a glecaprevir/pibrentasvir regimen

Adolfo de Salazar, Julia Dietz, Velia Chiara Di Maio,

Journal of Antimicrobial Chemotherapy

2020

21

Clinical trial: cyclophosphamide pulse therapy – a promising therapeutic alternative in refractory Crohn’s disease

K. J. Schmidt, Klaus Fellermann, Peter Wellhöner,

Alimentary Pharmacology & Therapeutics

2009

17

Efficacy of Retreatment After Failed Direct-acting Antiviral Therapy in Patients With HCV Genotype 1–3 Infections

Julia Dietz, Ulrich Spengler, Beat Müllhaupt,

Clinical Gastroenterology and Hepatology

2019

13

Page 1